Cargando…

Sex difference in disease burden of inflammatory arthritis patients treated with tumor necrosis factor inhibitors as part of standard care

OBJECTIVE: Knowledge is needed on the total disease burden across the sexes in inflammatory arthritis (IA). We aimed to compare disease burden, including a broad range of health aspects, across men and women with IA treated with tumor necrosis factor inhibitors (TNFi). METHODS: Adult outpatients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michelsen, Brigitte, Berget, Kristine Thomassen, Loge, Jon Håvard, Kavanaugh, Arthur, Haugeberg, Glenn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071161/ https://www.ncbi.nlm.nih.gov/pubmed/35511905 http://dx.doi.org/10.1371/journal.pone.0266816

Ejemplares similares

Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study
por: Michelsen, Brigitte, et al.
Publicado: (2022)

Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era
por: Haugeberg, Glenn, et al.
Publicado: (2020)

Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates
por: Haugeberg, Glenn, et al.
Publicado: (2020)

A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis
por: Michelsen, Brigitte, et al.
Publicado: (2015)

Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
por: Haugeberg, Glenn, et al.
Publicado: (2018)

Achilles enthesitis defined by ultrasound is not associated with clinical enthesitis in patients with psoriatic arthritis
por: Michelsen, Brigitte, et al.
Publicado: (2017)

Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population
por: Gulati, Agnete Malm, et al.
Publicado: (2018)

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
por: Hoff, Mari, et al.
Publicado: (2011)

Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3
por: Gulati, Agnete Malm, et al.
Publicado: (2017)

Effect of high-intensity interval training on cardiovascular disease risk factors and body composition in psoriatic arthritis: a randomised controlled trial
por: Thomsen, Ruth Stoklund, et al.
Publicado: (2018)

Changes of inflammation in patients with psoriatic arthritis after high intensity interval training assessed by ultrasound and MRI, a randomized controlled trial
por: Thomsen, Ruth Stoklund, et al.
Publicado: (2023)

Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trøndelag Health Study (HUNT)
por: Gulati, Agnete Malm, et al.
Publicado: (2018)

Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
por: Haugeberg, Glenn, et al.
Publicado: (2015)

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss
por: Hoff, Mari, et al.
Publicado: (2007)

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023)

Fatigue in myasthenia gravis: is it more than muscular weakness?
por: Elsais, Ahmed, et al.
Publicado: (2013)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008)

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis
por: Haugeberg, Glenn, et al.
Publicado: (2014)

Psoriatic arthritis: Pathogenesis and novel immunomodulatory approaches to treatment
por: Cassell, Sarah, et al.
Publicado: (2005)

Long-term drug effectiveness and survival for reference rituximab in rheumatoid arthritis patients in an ordinary outpatient clinic
por: Łosińska, Katarzyna, et al.
Publicado: (2022)

Decentralizing healthcare in Norway to improve patient-centered outpatient clinic management of rheumatoid arthritis – a conceptual model
por: Brkic, Alen, et al.
Publicado: (2021)

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis
por: Brkic, Alen, et al.
Publicado: (2022)

Cancer patients’ knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study
por: Berger, Ola, et al.
Publicado: (2018)

Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis
por: Huynh, D H, et al.
Publicado: (2017)

Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
por: Haugeberg, Glenn, et al.
Publicado: (2014)

Sleep problems in Parkinson's disease: a community-based study in Norway
por: Svensson, Elisabeth, et al.
Publicado: (2012)

Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis
por: Helliwell, Philip, et al.
Publicado: (2014)

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2018)

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
por: Ogdie, Alexis, et al.
Publicado: (2023)

Tailoring the delivery of cancer diagnosis to adolescent and young adult patients displaying strong emotions: An observational study of two cases
por: Korsvold, Live, et al.
Publicado: (2016)

Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship
por: Dahl, Alv A., et al.
Publicado: (2020)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
por: Kavanaugh, Arthur, et al.
Publicado: (2018)

Effects of a 1-Week Inpatient Course Including Information, Physical Activity, and Group Sessions for Prostate Cancer Patients
por: Gjerset, Gunhild Maria, et al.
Publicado: (2011)

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
por: Lebwohl, Mark G., et al.
Publicado: (2015)

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
por: Deyab, Gia, et al.
Publicado: (2017)

Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis
por: Song, Yan, et al.
Publicado: (2019)

Symptoms in the general Norwegian adult population - prevalence and associated factors
por: Krogstad, Hilde, et al.
Publicado: (2020)

Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy
por: Provan, Sella Aarrestad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_er995es50p2c9vdcpn4rehj9va